Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks. (Q51378688)
Jump to navigation
Jump to search
scientific article published in June 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks. |
scientific article published in June 2011 |
Statements
1 reference
Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks. (English)
1 reference
A Pfützner
1 reference
E Paz-Pacheco
1 reference
E Allen
1 reference
R Frederich
1 reference
R Chen
1 reference
CV181039 Investigators
1 reference
1 June 2011
1 reference
13
1 reference
6
1 reference
567-576
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference